[Therapy of coronary heart disease using Cormelian-Digotab: influence of the duration of therapy. 2. Field study by 107 physicians].
D001381:Azepines / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004077:Digoxin / Q000008:administration & dosage* / Q000031:analogs & derivatives; D004109:Dilazep / Q000008:administration & dosage*; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans
D001381:Azepines; D004338:Drug Combinations; D004077:Digoxin; D004109:Dilazep
Zur Therapie der koronaren Herzkrankheit mit Cormelian-Digotab: Einfluss der Behandlungsdauer. 2. Mitteilung über einen Feldversuch bei 107 niedergelassenen Arzten